AB-680 is primarily used in the field of medical research and drug development. It is an inhibitor that targets specific enzymes involved in immune regulation, making it a potential candidate for treating autoimmune diseases and certain types of cancer. Researchers are exploring its efficacy in modulating immune responses to enhance therapeutic outcomes. Its application is particularly significant in developing treatments that require precise control of immune system activity to prevent overactivation or suppression. Ongoing studies aim to validate its safety and effectiveness in clinical settings, potentially leading to new therapeutic options for patients with complex immune-related conditions.